HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Lazurite® Names Dr. Christopher Proctor to its Medical Advisory Board
“We are honored to have Dr. Christopher Proctor join our medical advisory board,” Lazurite CEO and cofounder Eugene Malinskiy said. “He was an early adopter of our ArthroFree® Wireless Surgical Camera System and has provided significant insight into the customer experience of adopting a wireless surgical camera. In addition to his accomplishments as a physician, he has also developed and patented devices, so he understands and appreciates innovation in medicine.”
Broken String Biosciences Strengthens Senior Leadership Team
Bringing significant expertise in their respective fields, Vincent Smith, PhD and Jessica Rich appointments are a key part of Broken String’s strategy to deliver on its Series A goals, which include the continued development of its INDUCE-seq™ DNA break-mapping platform and acceleration of its commercial expansion across global markets.
New Chief Sales Officer at Encare with Focus on Continued Global Expansion
The HealthTech company Encare has recruited Lotta Sellén as the new Chief Sales Officer (CSO). Lotta Sellén has solid experience in the pharmaceutical, healthcare and HealthTech industries.
CorWave Appoints Magalie Durrèche as Chief Financial Officer
Magalie Durrèche will oversee the financial management and participate in the strategic planning and fundraising of CorWave, a company developing and manufacturing a blood pump based on breakthrough technology. She succeeds Zina Hamoumi, who served as Chief Financial Officer for five years before deciding to focus on other projects.
Veracyte Names Dr Phillip G Febbo Chief Scientific Officer and Chief Medical Officer
“Phil G Febbo is an exceptional leader with a strong track record of driving successful commercialization of molecular tests through evidence development, guideline inclusion and key opinion leader support,” said Mr. Stapley. “His experience and expertise will be critical to further enhancing our ability to serve our customers and, ultimately, to transforming cancer care for patients all over the world.”
GrayMatters Health Expands US Executive Team, Including Appointment of Dr Aron Tendler as Chief Medical Office
Dr Aaron Tendler is a board-certified psychiatrist based in Palm Beach, Florida, bringing over 20 years of experience as an industry leader researching novel treatments for mental health disorders.
Carthera Appoints Dr Oern Stuge as Chairman of Board of Directors
Dr Oern Stuge brings 30+ years expertise with a wealth of experience in product development and commercial launches to support Carthera’s future growth.
Cytomos Appoints a New Director as £4 Mill Investment Sets Path for Commercialisation of Groundbreaking Cell Analysis Technology
The biotech company’s appointment of industry leader Dr Sharon Brownlow as Non-Executive Director further enhances Cytomos’ senior management team and its unique value proposition to key industry markets.
Kindeva Drug Delivery Appoints Brian Schubmehl as Chief Human Resources Officer
Brian Schubmehl brings more than two decades of diverse and senior global leadership expertise that has spanned private equity, startup, and publicly traded organizations.
